Multidrug-Resistant Tuberculosis
Outbreak among US-bound Hmong
Refugees, Thailand, 2005
John E. Oeltmann

, Jay K. Varma, Luis Ortega, Yecai Liu, Thomas O’Rourke, Maria Cano, Theresa A. Harrington, Sean Toney, Warren Jones, Samart Karuchit, Lois Diem, Dhanida Rienthong, Jordan W. Tappero, Kashef Ijaz, and Susan A. Maloney
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (J.E. Oeltmann, L. Ortega, Y. Liu, M. Cano, T. Harrington, S. Toney, L. Diem, K. Ijaz, S.A. Maloney); Thailand Ministry of Public Health–US Centers for Disease Control and Prevention Collaboration, Bangkok, Thailand (J.K. Varma, S. Karuchit, J.W. Tappero); The International Organization for Migration, Bangkok (T. O’Rourke, W. Jones); Thailand Ministry of Public Health, Bangkok (D. Rienthong);
Main Article
Table 2
Mycobacterium tuberculosis drug-susceptibility test results, by genotype, Hmong refugee tuberculosis patients, Thailand, February 2005*
Genotype cluster |
Isolate results
|
Some resistance |
MDR TB |
Pansusceptible |
Total |
Unique isolates |
5 |
3 |
8 |
16 |
A |
0 |
0 |
3 |
3 |
B |
0 |
0 |
2 |
2 |
C |
0 |
20 |
0 |
20 |
D |
0 |
0 |
2 |
2 |
E |
1 |
0 |
2 |
3 |
Total |
6 |
23 |
17 |
46 |
Main Article
Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.